Employer record · Watertown, MA · FY2021–FY2026
Orna Therapeutics, Inc.
USCIS approval rateFY24–26 · 12 approved
- Certified LCAs
- 13
- FY2024–FY2026
- USCIS approvals
- 12
- 10 new employment
- Denial rate
- 7.7%
- FY2024–FY2026
- Median wage offered
- $135k
- certified LCAs
Does Orna Therapeutics, Inc. sponsor H-1B visas?
Yes — by its record, Orna Therapeutics, Inc. is an occasional H-1B sponsor: it filed 13 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 12 USCIS H-1B petition approvals (10 for new employment). Its latest certified LCA in our data was decided Jul 16, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Top sponsors in Massachusetts →Scientific research and development sponsors →Sponsors based in Watertown →
Filings by fiscal year
Certified LCAs per U.S. government fiscal year (Oct–Sep) — 21 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.
| Fiscal year | certified LCAs | USCIS approvals | Approval rate |
|---|---|---|---|
| FY21 | 1 | 1 | 100% |
| FY22 | 2 | 2 | 100% |
| FY23 | 5 | 4 | 100% |
| FY24 | 1 | 1 | 100% |
| FY25 | 7 | 9 | 90% |
| FY26 | 5 | 2 | 100% |
Occupations sponsored
| Occupation (SOC) | LCAs | Median wage |
|---|---|---|
| Molecular and Cellular Biologists 19-1029 | 9 | $189k |
| Chemists 19-2031 | 3 | $151k |
| Biochemists and Biophysicists 19-1021 | 1 | $161k |
Most-filed job titles
- Associate Scientist6$110k
- Senior Scientist5$155k
- Principal Scientist1$189k
- Senior Scientist NGS1$155k
LCAs per title and median wage offered.
Where the jobs were
- Massachusetts12 LCAs
- Maryland1 LCAs
We haven't indexed Orna Therapeutics' jobs yet
We read jobs straight from employers' own career sites and haven't added Orna Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.
Also filed as
- ORNA THERAPEUTICS INC (USCIS)
- Orna Therapeutics, Inc. (LCA)
- ORNA THERAPEUTICS, INC. (USCIS)
Orna Therapeutics, Inc. H-1B: questions people ask
Does Orna Therapeutics, Inc. sponsor H-1B visas?
Yes — by its record, Orna Therapeutics, Inc. is an occasional H-1B sponsor: it filed 13 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 12 USCIS H-1B petition approvals (10 for new employment). Its latest certified LCA in our data was decided Jul 16, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Is Orna Therapeutics, Inc. still sponsoring H-1B in 2026?
Orna Therapeutics, Inc. had 5 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 7 in FY2025. The latest one in our data was decided Jul 16, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.
How many H-1B petitions does Orna Therapeutics, Inc. get approved?
USCIS recorded 12 approvals (10 for new employment, the rest continuing employment such as extensions and transfers) and 1 denials for Orna Therapeutics, Inc. in FY2024–FY2026 — a denial rate of 7.7%. Source: USCIS H-1B Employer Data Hub (first decisions).
What is the H-1B salary at Orna Therapeutics, Inc.?
The median wage offered on Orna Therapeutics, Inc.'s certified LCAs in FY2024–FY2026 was $135k a year. By job title: Associate Scientist $110k (6 LCAs), Senior Scientist $155k (5 LCAs) and Principal Scientist $189k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.
Which jobs does Orna Therapeutics, Inc. sponsor for H-1B?
Its certified LCAs in FY2024–FY2026 were mostly for Molecular and Cellular Biologists (9), Chemists (3) and Biochemists and Biophysicists (1).
Where are Orna Therapeutics, Inc.'s H-1B jobs?
By worksite on its certified LCAs (FY2024–FY2026): Massachusetts (12) and Maryland (1).
Is Orna Therapeutics, Inc. an H-1B dependent employer?
No — its recent LCAs do not declare it H-1B dependent.
Does Orna Therapeutics, Inc. have open jobs?
We read jobs straight from employers' own career sites and haven't added Orna Therapeutics' yet.